Semaglutide treatment of antipsychotic-treated patients with schizophrenia, prediabetes, and obesity: the HISTORI randomized clinical trial
Ganeshalingam AA, Uhrenholt N, Arnfred S, et al.
JAMA Psychiatry. Pub. online 3 Sep 2025.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Automated insulin delivery systems and glucose management in children and adolescents with type 1 diabetes: a systematic review and meta-analysis
de Visser HS, Waraich S, Chhabra M, et al.
JAMA Pediatr. Pub. online 8 Sep 2025.
Leggi
Clinical features modifying the cardiovascular benefits of GLP-1 receptor agonists: a systematic review and meta-analysis
Kalayci A, Januzzi JL, Mitsunami M, et al.
Eur Heart J Cardiovasc Pharmacother. Pub. online 31 Aug 2025.
Leggi
Advancing type 1 diabetes management: integrating novel therapies, technologies, and adjunctive approaches
Snaith JR, Narongkiatikhun P, Bjornstad P, et al.
Diabetes Care. Pub. online 29 Aug 2025.
Leggi
Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction
Krüger N, Schneeweiss S, Fuse K, et al.
JAMA. 2025:e2514092.
Leggi
Glycaemic control after connected insulin pen initiation in people living with diabetes: results from a real-world setting
Adolfsson P, Guerci B, Hartvig NV, et al.
Diabetes Obes Metab. Pub. online 28 Aug 2025.
Leggi
Comparison of an energy-reduced mediterranean diet and physical activity versus an ad libitum mediterranean diet in the prevention of type 2 diabetes : a secondary analysis of a randomized controlled trial
Ruiz-Canela M, Corella D, Martínez-González MÁ, et al.
Ann Intern Med. Pub. online 26 Aug 2025.
Leggi
Dapagliflozin in patients hospitalized for heart failure: primary results of the DAPA ACT HF-TIMI 68 randomized clinical trial and meta-analysis of sodium-glucose cotransporter-2 inhibitors in patients hospitalized for heart failure
Berg DD, Patel SM, Haller PM, et al.
Circulation. Pub. online 29 Aug 2025.
Leggi
Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data
Patsoukaki V, Lind L, Lampa E, et al.
Lancet Diabetes Endocrinol. 2025:S2213-8587(25)00165-2.
Leggi
Biomarkers for cardiovascular-kidney metabolic syndrome: clinical utility in diagnosis, screening, and treatment
Yau K, Cherney DZI, Odutayo A
Diabetes Obes Metab. Pub. online 26 Aug 2025.
Leggi